A high-throughput screening campaign against PFKFB3 identified potential inhibitors with novel scaffolds.
Li J, Zhou Y, Eelen G, Zhou QT, Feng WB, Labroska V, Ma FF, Lu HP, Dewerchin M, Carmeliet P, Wang MW, Yang DH.
Li J, et al. Among authors: ma ff.
Acta Pharmacol Sin. 2023 Mar;44(3):680-692. doi: 10.1038/s41401-022-00989-1. Epub 2022 Sep 16.
Acta Pharmacol Sin. 2023.
PMID: 36114272
Free PMC article.